Bioventix (LON:BVXP) Stock Price Passes Below 50 Day Moving Average – Should You Sell?

Posted by Tyrone Williams on Jan 6th, 2026

Shares of Bioventix PLC (LON:BVXP – Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 1,944.89 and traded as low as GBX 1,820. Bioventix shares last traded at GBX 1,875, with a volume of 8,173 shares traded.

Bioventix Stock Up 0.8%

The company has a market capitalization of £98.75 million, a PE ratio of 13.19 and a beta of 0.35. The company’s 50 day moving average is GBX 1,944.89 and its two-hundred day moving average is GBX 2,318.13.

Bioventix (LON:BVXP – Get Free Report) last announced its quarterly earnings results on Monday, October 27th. The biotechnology company reported GBX 145.27 EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. Analysts forecast that Bioventix PLC will post 166.3066955 EPS for the current year.

Insiders Place Their Bets

In other news, insider Bruce Hiscock bought 150 shares of the stock in a transaction dated Tuesday, November 25th. The stock was purchased at an average cost of GBX 2,071 per share, for a total transaction of £3,106.50. Also, insider Peter John Harrison purchased 875 shares of Bioventix stock in a transaction that occurred on Tuesday, November 4th. The stock was acquired at an average price of GBX 2,220 per share, for a total transaction of £19,425. Insiders have bought a total of 1,644 shares of company stock valued at $3,424,721 in the last quarter. 6.16% of the stock is currently owned by insiders.

Bioventix Company Profile

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.